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The recent finding that MTA1 interacts with CAK, a com-Another Tie that Binds the MTA
ponent of the TFIIH regulatory complex, suggests thatFamily to Breast Cancer MTA1 may also act as a signal transducer to mediate
crosstalk between corepressor complexes and the gen-
eral transcription machinery (Talukder et al., 2003).
Unexpectedly, MTA1 was also identified as a target
of growth factor signal transduction, and a role for MTA1In this issue of Cell, Fujita et al. (2003) demonstrate
in hormonal independence was suggested (Mazumdarthat MTA3 is an estrogen-dependent component of
et al., 2001). This study found downregulation of ligand-the NuRD complex and identify the Snail gene as its
induced ER transcriptional activity via recruitment ofdirect target. ER signaling upregulates MTA3 levels
HDACs to the ER. Another study showed that a naturallyto negatively modulate Snail-mediated repression of
occurring variant of MTA1, MTA1s, is overexpressed inE-cadherin. These findings may explain how ER status
ER-negative tumors (Kumar et al., 2002). MTA1s notcontrols epithelial-to-mesenchymal transition in hu-
only inhibits nuclear signaling by sequestering ER inman breast tumors.
the cytoplasm, but it also enhances ER cytoplasmic
signaling and, thus, promotes tumorigenesis. Together,
Estrogen plays an essential role in normal breast devel- these studies suggest a complex role for MTA1 and
opment and in breast cancer development and progres- MTA1s in blocking ER functions.
sion. Its biosynthesis is regulated by aromatase, the The report by Fujita et al. (2003 [this issue of Cell])
upregulation of which in breast cancer stimulates growth offers yet another connection between MTAs and the
in autocrine and paracrine manners. The principal target ER, identifying MTA3 as an ER-regulated component of
of estrogen, the estrogen receptor (ER), is found in 40%– the Mi2/NuRD complex and showing that its expression
70% of breast tumors at diagnosis, together with a pro- is downregulated in ER-negative breast tumors. Given
file of ER-regulated genes. ER-positive tumors generally the established role of MTA family members in the NuRD
are responsive to anti-hormonal therapy, although a sig- complex, it was perhaps expected that MTA3 also would
nificant proportion of patients with this class of tumor function in this repression complex. A pioneering aspect
do not respond to this therapy. In addition, most who of this study, however, is the finding that MTA3 is an ER-
do respond initially eventually develop hormone-inde- regulated gene and directly targets Snail. Modulation
pendent tumors characterized by an aggressive clinical of E-cadherin expression via MTA3- and ER-signaling-
course and increased metastasis. Little is known about mediated changes in Snail expression has important
the molecular mechanisms by which ER-negative tu- phenotypic implications, and the authors provide correl-
mors become aggressive and metastatic. ative data for the existence of this ER-MTA3-Snail path-
Although localized breast cancer can be cured by way in human breast tumor samples. Despite the impor-
surgery, breast cancer has a high mortality rate due tant implications, the biochemical studies of Fujita et al.
primarily to frequent metastasis while the primary tumor
have yet to undergo functional assessment in a physio-
is undetected. Metastasis requires, among other steps,
logically relevant model and, therefore, must be interpre-
alterations in signaling pathways and target gene prod-
ted with caution.
ucts, increased epithelial-to-mesenchymal transition
Identifying MTA3 as an ER-regulated gene supports(EMT), and aberrant expression and function of cell ad-
the idea that MTA members play an important role inhesion components. For example, loss of the cell adhe-
the ER pathway. Although earlier studies identifiedsion molecule E-cadherin leads to epithelial dedifferenti-
MTA1 and MTA2 as components of NuRD, Fujita et al.’sation and increased metastasis. This loss is largely due
results are exciting and provocative. The failure to detectto repression of the E-cadherin gene by the transcription
MTA1 and MTA2 in the MTA3-containing NuRD complexfactor Snail, the master regulator of EMT. Snail and
raises the possibility (adeptly proposed by the authors)aromatase levels can be inversely correlated in cancer
that different NuRD complexes with distinct subunits oftissue, and since Snail also downregulates aromatase
MTA family members exist. Whether this is true andexpression (Chen et al., 2001), Snail may influence the
whether they differ only in MTA family members or inlevels of circulating estrogen as well as the development
other distinct subunits as well needs to be determined.of hormone-independent, aggressive breast tumors.
What would be the normal functions of different NuRDsMetastasis-associated genes (MTAs) comprise a novel
with distinct MTA-member subunits?gene family with a growing number of members. Currently,
Fujita et al. conclusively establish that loss of ER re-there are three known genes encoding six isoforms (MTA1,
sults in decreased MTA3 expression, thus activatingMTA1s, MTA-ZG29p, MTA2, MTA3, MTA3L) (Wang and
Snail expression and, inferentially, EMT. The authorsKumar, 2003; Fujita et al., 2003). MTA1 was identified as
suggest that this pathway may have a role in the metas-a differentially expressed gene in rat metastatic tumors
tasis phenotype observed in ER-negative tumors. These(Toh et al., 1994). Later studies identified other family
data, however, also raise the new hypothesis that thismembers, including MTA3 (Simpson, et al., 2001).
pathway may be involved in ER-positive MTA1 deregu-Since MTA proteins do not seem to possess enzymatic
lated tumors. Since MTA1 and MTA1s are potent repres-activity, the mechanism(s) of their function remains a
sors of nuclear ER functions, deregulation of these pro-mystery. The discovery that MTA1 is part of a nuclear
teins may also downregulate MTA3 expression via ERremodeling and deacetylation complex (NuRD) sug-
repression, which can then lead to enhanced Snail ex-gested that the major function of these proteins might
be to form a repressive chromatin state (Xue et al., 1998). pression and EMT. In addition, Snail-mediated repres-
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the question of whether MTA3 regulation is specific to
ER or ER. It will be important to know if MTA3 expres-
sion is deregulated in other hormone-dependent/hor-
mone-resistant cancers, and if restoring MTA3 expres-
sion can reduce the metastatic potential of cancer cells.
All the known MTA family members are widely ex-
pressed in normal tissues, so understanding MTA activi-
ties in normal development is critical. It is equally impor-
tant to understand how MTA family members regulate
NuRD complex activity. Since MTAs contain several pro-
tein-protein interaction motifs, identifying potential
binding proteins will help elucidate the function of MTA
genes. Identification of potential targets of each MTA
family member is another worthy goal.
Figure 1. Regulatory Interplay between MTA Family Members and MTA members are overexpressed in metastatic tu-
ER Pathways mors, are part of NuRD complexes, and are regulated by
Estrogen binding to ER leads to increased expression of MTA3, growth factors/oncogenes. They modulate ER functions
which in turn represses the expression of Snail, allowing upregula- and may participate in EMT. These data suggest that
tion of E-cadherin expression and cell adhesiveness. The loss of
MTA proteins play an important and fundamental roleER and the blockage of ER’s nuclear functions by MTA1 and MTA1s
in pathological processes. The report by Fujita et al.could interrupt ER regulation of MTA3 expression, permitting ele-
vated levels of Snail to suppress E-cadherin expression. These bio- should provide impetus for future studies directed at
chemical alterations in the levels of Snail and E-cadherin promote increasing our understanding of the functions and regu-
loss of epithelial cell adhesion while enhancing EMT and invasive- lation of MTA family members.
ness. Repression of aromatase expression by Snail can also contrib-
ute toward the development of ER-negative phenotypes. Black solid
lines, activation pathways; red solid lines, inhibitory pathways; bro-
ken lines, postulated pathways yet to be validated; MTA-BPs, MTA Rakesh Kumar
binding proteins; CoA, ER coactivators. Department of Molecular and Cellular Oncology
The University of Texas M.D. Anderson Cancer Center
Houston, Texas 77030
sion of the aromatase gene will inhibit ER regulation of
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